Prevalence and Determinants of Psychiatric Morbidities in Nigerian Men with LUTS Due to Prostatic Diseases
Asian Journal of Medicine and Health,
Aims: This study aimed at determining the prevalence and significant factors associated with psychiatric morbidity in men with LUTS secondary to prostatic diseases in a tertiary health centre in a developing country.
Study design: This is a prospective, cross-sectional study.
Place and duration: The urology unit of Ekiti State University Teaching Hospital, Ado-Ekiti. Ekiti State, Nigeria. The study period was from 1stJanuary2018 to 31stDecember2019.
Methodology: Hospital Anxiety and Depression Scale (HADS) was used to assess for psychiatric morbidity among 224 patients with LUTS. While, International prostate symptom score (IPSS) was used to assess the severity of LUTS. The data was analysed using SPSS version 20.
Results: The prevalence of depression and anxiety were 17% and 9.8% respectively. The mean IPSS and PSA scores of the respondents were 19.95±8.06 and 31.48±37.03 respectively. The only factors found to be significantly associated with depression were use of alcohol by the respondents (T-test = .058, P = .01, CI = -2.885 ˗˗ -0.391) and high scores on IPSS (T-test = .765, P value = .003, CI = 1.436 ˗˗ 6.995). While the factors found to be associated with anxiety disorders were alcohol use by the respondents (T-test =2.661, P = .033, CI = -2.519 ˗˗ -0.103) and high PSA scores (T-test =9.473, P value = .036, CI = -28.942 ˗˗ -1.068).
Conclusion: This study shows that there is a high rate of psychiatric morbidity among patients with LUTS. Main factors associated with these morbidities were alcohol use, severity of the LUTS and high PSA scores. Assessment of psychiatric morbidity in patients with LUTS using simple psychological instruments will help in early detection and prompt treatment of psychological morbidities.
- psychological morbidity
- urinary tract obstruction
How to Cite
Kupelian V, McVary KT, Kaplan SA, Hall SA, Link CL, Aiyer LP, et al. Association of lower urinary tract symptoms and the metabolic syndrome. Results from the Boston Area Community Health (BACH) Survey. J Urol. 2009;182(2):616–25.
Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80(1):90–6.
Hung S-F, Chung S-D, Kuo H-C. Increased Serum C-Reactive Protein Level Is Associated with Increased Storage Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia. PLOS ONE. 2014;9(1):e85588.
Elstad EA, Taubenberger SP, Botelho EM, Tennstedt SL. Beyond incontinence: the stigma of other urinary symptoms. J Adv Nurs. 2010;66(11):2460–70.
Suen LKP, Cheng HL, Yeung SKW, Au-Yeung CH, Lee JCY, Ho KKY, et al. Qualitative insights into the experiences of living with moderate-to-severe lower urinary tract symptoms among community-dwelling ageing males. 2017 [cited 2021 Oct 3];
Wong SYS, Hong A, Leung J, Kwok T, Leung PC, Woo J. Lower urinary tract symptoms and depressive symptoms in elderly men. J Affect Disord. 2006 ;96(1–2):83–8.
Nilsson M, Lalos O, Lindkvist H, Lalos A. Impact of female urinary incontinence and urgency on women’s and their partners’ sexual life. Neurourol Urodyn. 2011;30(7):1276–80.
Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103 Suppl 3:4–11.
Temi AP, Usman DM, Ademola I, Emmanuel OA, Olutoyin OL, Adetunji O. Pre-treatment Depression and Anxiety Disorder in Men with Cancer of the Prostate in South Western Nigeria. INDJ. 2021;46–53.
Jeong WS, Choi HY, Nam JW, Kim SA, Choi BY, Moon HS, et al. Men With Severe Lower Urinary Tract Symptoms Are at Increased Risk of Depression. Int Neurourol J. 2015;19(4):286–92.
Pietrzyk B, Olszanecka-Glinianowicz M, Owczarek A, Gabryelewicz T, Almgren-Rachtan A, Prajsner A, et al. Depressive symptoms in patients diagnosed with benign prostatic hyperplasia. Int Urol Nephrol. 2015;47(3):431–40.
Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology. 1995;45(6):1007–13; discussion 1013-1015.
Harris JL. Treatment of postprostatectomy urinary incontinence with behavioral methods. Clin Nurse Spec. 1997;11(4):159–66.
Nicolson P, Kopp Z, Chapple CR, Kelleher C. It’s just the worry about not being able to control it! A qualitative study of living with overactive bladder. Br J Health Psychol. 2008;13(Pt 2):343–59.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.
Zhang W, Cao G, Sun Y, Wu F, Wang Q, Xu T, et al. Depressive symptoms in individuals diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in middle-aged and older Chinese individuals: Results from the China Health and Retirement Longitudinal Study. Journal of Affective Disorders [Internet]. 2021 Sep 20 [cited 2021 Sep 29];
Huang C-Y, Chiu K-M, Chung S-D, Keller JJ, Huang C-C, Lin H-C. Increased risk of depressive disorder following the diagnosis of benign prostatic enlargement: one-year follow-up study. J Affect Disord. 2011;135(1–3):395–9.
Özen MA, Mutluer T, Necef I, Shabsog M, Taşdemir M, Bilge I, et al. The overlooked association between lower urinary tract dysfunction and psychiatric disorders: a short screening test for clinical practice. J Pediatr Urol. 2019;15(4):332.e1-332.e5.
Steers et al. Overactive bladder, urge incontinence and emotional disorders. 2008;(27):137_147.
Laumann EO, Kang J, Glasser DB, Rosen RC, Carson CC. Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States. J Urol. 2008;180(1):233–40.
Klausner AP, Steers WD. Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol. 2004;172(6 Pt 2):2570–3.
Miller AH, Maletic V, Raison CL. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression. Biol Psychiatry. 2009;65(9):732–41.
Dunphy C, Laor L, Te A, Kaplan S, Chughtai B. Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Rev Urol. 2015;17(2):51–7.
Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011;106(5):906–14.
Coêlho BM, Andrade LH, Guarniero FB, Wang Y-P. The influence of the comorbidity between depression and alcohol use disorder on suicidal behaviors in the São Paulo Epidemiologic Catchment Area Study, Brazil. Braz J Psychiatry. 2010;32(4):396–408.
Uluocak N, Kulu M, Acar O, Atilgan D, Parlaktas BS, Kilic S, et al. Is There A Relationship Between Alcohol/Drug Abuse And Luts/Ed? 2016 [cited 2021 Oct 5];
Abstract View: 53 times
PDF Download: 30 times